Association of Methylenetetrahydrofolate Reductase C677T Polymorphism with Hyperhomocysteinemia and Deep Vein Thrombosis in the Iranian Population.
10.5758/vsi.2015.31.4.109
- Author:
Habib GHAZNAVI
1
;
Zahra SOHEILI
;
Shahram SAMIEI
;
Mohammad Soleiman SOLTANPOUR
Author Information
1. Cellular and Molecular Research Centre, Zahedan University of Medical Sciences, Zahedan, Iran.
- Publication Type:Original Article
- Keywords:
Homocysteine;
Deep venous thrombosis;
Methylenetetrahydrofolate reductase;
Genetic polymorphism
- MeSH:
Alleles;
Diagnosis;
Female;
Genotype;
Heterozygote;
Homocysteine;
Homozygote;
Humans;
Hyperhomocysteinemia*;
Immunoenzyme Techniques;
Male;
Methylenetetrahydrofolate Reductase (NADPH2)*;
Mortality;
Plasma;
Polymerase Chain Reaction;
Polymorphism, Genetic;
Risk Factors;
Venous Thrombosis*
- From:Vascular Specialist International
2015;31(4):109-114
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Deep venous thrombosis (DVT) is a common but elusive condition characterized by a high morbidity and mortality rate. The aim of the present study was to investigate the correlation between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with plasma total homocysteine (tHcy) levels and DVT risk in an Iranian population. MATERIALS AND METHODS: Our study population consisted of 67 patients with a diagnosis of DVT and 67 healthy subjects as controls. Genotyping of MTHFR C677T polymorphism was performed by the polymerase chain reaction technique combined with restriction enzyme fragment length polymorphism (PCR-RFLP) and measurement of tHcy levels was done by enzyme immunoassay method. RESULTS: Plasma tHcy levels were significantly higher in DVT patients than controls (18.09+/-7.6 vs. 10.5+/-4.3, P=0.001). Also, plasma tHcy levels were significantly higher in MTHFR 677TT genotypes compared to 677CC genotypes in both DVT patients (P=0.016) and controls (P=0.03). Neither heterozygote nor homozygote genotypes of MTHFR C677T polymorphism was significantly correlated with DVT (P>0.05). The distribution of MTHFR C677T genotypes was similar between men and women in both DVT patients and controls (P>0.05). Moreover, the frequency of mutant 677T allele did not differ significantly between the two groups (28.3% vs. 21.6%, P=0.15). CONCLUSION: Based on this study, we propose that hyperhomocysteinemia but not homozygosity for MTHFR C677T polymorphism is a significant risk factor for DVT in the Iranian population. Also, MTHFR 677TT genotype is a determinant of elevated plasma tHcy levels.
